Zura Bio Ltd (ZURA)
Zura Bio Reports Second Quarter 2025 Financial Results and Recent Corporate Updates
Nuwellis Inc. (NUWE)
Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights
Verastem Inc (VSTM)
uniQure NV (QURE)
Candel Therapeutics Inc (CADL)
Taysha Gene Therapies (TSHA)
Xilio Therapeutics Inc. (XLO)
Tarsus Pharmaceuticals Inc (TARS)
MeiraGTx Holding (MGTX)
Candel Therapeutics Inc (CADL)
Exagen Inc (XGN)
Organovo Holdings Inc. (ONVO)
New Form 8-K - VivoSim Labs, INC. Filed: 2025-08-14 AccNo: 0000950170-25-108447 Size: 252 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Compass Therapeutics Inc. (CMPX)
VYNE Therapeutics Inc. (VYNE)
New Form 8-K - VYNE Therapeutics Inc. Filed: 2025-08-14 AccNo: 0001104659-25-078135 Size: 293 KB Item 2.02: Results of Operations and Financial Condition Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits